Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 782-784
- https://doi.org/10.1016/0959-8049(95)00092-w
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The intergroup rhabdomyosarcoma study-IICancer, 1993
- Treatment of soft tissue sarcoma in childhood and adolescence: A report of the german cooperative soft tissue sarcoma studyCancer, 1992
- Rapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomasBritish Journal of Cancer, 1991
- ‘MACHO’ chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhoodBritish Journal of Haematology, 1990
- An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the international society of pediatric oncology (SIOP)Medical and Pediatric Oncology, 1989
- Intensive chemotherapy including cisplatin with or without etoposide for children with soft‐tissue sarcomasMedical and Pediatric Oncology, 1986
- Successful management of metastatic and primary germ cell tumors in the brainCancer, 1986
- VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancerCancer, 1984
- Review of etoposide single-agent activityCancer Treatment Reviews, 1982
- In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinomaEuropean Journal of Cancer and Clinical Oncology, 1982